Clinical Trial Update: A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ociperlimab with tislelizumab versus pembrolizumab in untreated non-small cell lung cancer; the study is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ociperlimab (ociperlimab)
• Pembrolizumab (pembrolizumab)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Non-small Cell Lung Cancer, NSCLC | Phase 3 | Status: ACTIVE_NOT_RECRUITING